268 related articles for article (PubMed ID: 9263352)
1. Erythromelalgia: a pathognomonic microvascular thrombotic complication in essential thrombocythemia and polycythemia vera.
van Genderen PJ; Michiels JJ
Semin Thromb Hemost; 1997; 23(4):357-63. PubMed ID: 9263352
[TBL] [Abstract][Full Text] [Related]
2. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia.
Michiels JJ; Berneman Z; Schroyens W; Koudstaal PJ; Lindemans J; Neumann HA; van Vliet HH
Platelets; 2006 Dec; 17(8):528-44. PubMed ID: 17127481
[TBL] [Abstract][Full Text] [Related]
3. Erythromelalgia--a thrombotic complication in chronic myeloproliferative disorders.
Tarach JS; Nowicka-Tarach BM; Matuszek B; Nowakowski A
Med Sci Monit; 2000; 6(1):204-8. PubMed ID: 11208311
[TBL] [Abstract][Full Text] [Related]
4. Aspirin-responsive painful red, blue, black toe, or finger syndrome in polycythemia vera associated with thrombocythemia.
Michiels JJ; Berneman Z; Schroyens W; van Urk H
Ann Hematol; 2003 Mar; 82(3):153-9. PubMed ID: 12634947
[TBL] [Abstract][Full Text] [Related]
5. Platelet consumption in thrombocythemia complicated by erythromelalgia: reversal by aspirin.
van Genderen PJ; Michiels JJ; van Strik R; Lindemans J; van Vliet HH
Thromb Haemost; 1995 Feb; 73(2):210-4. PubMed ID: 7792731
[TBL] [Abstract][Full Text] [Related]
6. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.
Michiels JJ; Berneman Z; Van Bockstaele D; van der Planken M; De Raeve H; Schroyens W
Semin Thromb Hemost; 2006 Apr; 32(3):174-207. PubMed ID: 16673274
[TBL] [Abstract][Full Text] [Related]
7. Aspirin-responsive, migraine-like transient cerebral and ocular ischemic attacks and erythromelalgia in JAK2-positive essential thrombocythemia and polycythemia vera.
Michiels JJ; Berneman Z; Gadisseur A; Lam KH; De Raeve H; Schroyens W
Acta Haematol; 2015; 133(1):56-63. PubMed ID: 25116182
[TBL] [Abstract][Full Text] [Related]
8. Aspirin for the control of platelet activation and prevention of thrombosis in essential thrombocythemia and polycythemia vera: current insights and rationale for future studies.
Landolfi R; Di Gennaro L; Novarese L; Patrono C
Semin Thromb Hemost; 2006 Apr; 32(3):251-9. PubMed ID: 16673279
[TBL] [Abstract][Full Text] [Related]
9. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.
Michiels JJ; Berneman Z; Schroyens W; Finazzi G; Budde U; van Vliet HH
Semin Thromb Hemost; 2006 Sep; 32(6):589-604. PubMed ID: 16977569
[TBL] [Abstract][Full Text] [Related]
10. Erythromelalgia and vascular complications in polycythemia vera.
Michiels JJ
Semin Thromb Hemost; 1997; 23(5):441-54. PubMed ID: 9387203
[TBL] [Abstract][Full Text] [Related]
11. Platelet-mediated thrombotic complications in patients with ET: Reversal by aspirin, platelet reduction, and not by coumadin.
Michiels JJ; Berneman Z; Schroyens W; Koudstaal PJ; Lindemans J; van Vliet HH
Blood Cells Mol Dis; 2006; 36(2):199-205. PubMed ID: 16510297
[TBL] [Abstract][Full Text] [Related]
12. Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis in thrombocythemia.
Michiels JJ; Abels J; Steketee J; van Vliet HH; Vuzevski VD
Ann Intern Med; 1985 Apr; 102(4):466-71. PubMed ID: 3977194
[TBL] [Abstract][Full Text] [Related]
13. Erythromelalgia in patients with essential thrombocythemia and polycythemia vera.
Hou JL; Onajin O; Gangat N; Davis MD; Wolanskyj AP
Leuk Lymphoma; 2017 Mar; 58(3):715-717. PubMed ID: 27684959
[No Abstract] [Full Text] [Related]
14. Aspirin in polycythemia vera and essential thrombocythemia: current facts and perspectives.
Landolfi R; Patrono C
Leuk Lymphoma; 1996 Sep; 22 Suppl 1():83-6. PubMed ID: 8951777
[TBL] [Abstract][Full Text] [Related]
15. [Histopathologic lesions in erythromelalgia during essential thrombocythemia].
Croue A; Gardembas-Pain M; Verret JL; Boasson M; Rousselet MC; Saint Andre JP
Ann Pathol; 1993; 13(2):128-30. PubMed ID: 8363673
[TBL] [Abstract][Full Text] [Related]
16. Erythromelalgic, thrombotic and hemorrhagic manifestations in 50 cases of thrombocythemia.
Michiels JJ; van Genderen PJ; Lindemans J; van Vliet HH
Leuk Lymphoma; 1996 Sep; 22 Suppl 1():47-56. PubMed ID: 8951772
[TBL] [Abstract][Full Text] [Related]
17. Thrombosis and bleeding in polycythemia vera and essential thrombocythemia: pathogenetic mechanisms and prevention.
Landolfi R; Cipriani MC; Novarese L
Best Pract Res Clin Haematol; 2006; 19(3):617-33. PubMed ID: 16781491
[TBL] [Abstract][Full Text] [Related]
18. Platelet-mediated microvascular inflammation and thrombosis in thrombocythemia vera: a distinct aspirin-responsive arterial thrombophilia, which transforms into a bleeding diathesis at increasing platelet counts.
Michiels JJ
Pathol Biol (Paris); 2003 Apr; 51(3):167-75. PubMed ID: 12781799
[TBL] [Abstract][Full Text] [Related]
19. Erythromelalgia and myeloproliferative disorders.
Kurzrock R; Cohen PR
Arch Intern Med; 1989 Jan; 149(1):105-9. PubMed ID: 2643412
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology and treatment of platelet-mediated microvascular disturbances, major thrombosis and bleeding complications in essential thrombocythaemia and polycythaemia vera.
Michiels JJ; Berneman ZN; Schroyens W; Van Vliet HH
Platelets; 2004 Mar; 15(2):67-84. PubMed ID: 15154599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
